Orforglipron vs Dapagliflozin in Type 2 Diabetes: What the ACHIEVE-2 Trial Found 11th July 2026 by Living Diabetes Editorial ACHIEVE-2 compared oral orforglipron with dapagliflozin in adults with type 2 diabetes. Learn about HbA1c, weight, side effects, and study limits.
Amycretin: What to Know About This Investigational GLP-1 and Amylin Medicine 6th June 20266th April 2026 by Living Diabetes Editorial Team Amycretin is an investigational GLP-1 and amylin medicine. Learn what early studies show, what is still unknown, and safety caveats.
